Whitney K. Hendrickson,
MD
Languages Spoken: English
Dr. Whitney Hendrickson is a fellowship trained Urogynecologist and women’s health provider in the Urogynecology and Pelvic Reconstructive Surgery division.
Dr. Whitney Hendrickson received her M.D. from University of Massachusetts. She completed her Obstetrics and Gynecology residency from UC San Diego in San Diego, California. Following residency, Dr. Hendrickson completed a fellowship in Female Pelvic Medicine and Reconstructive Surgery at Duke University in Durham, North Carolina. Dr. Hendrickson’s clinical interest include the medical and surgical treatment of pelvic organ prolapse and urinary incontinence, especially those women whose initial treatments have not been successful. She is accepting new patients with pelvic floor disorders.
Dr. Hendrickson’s research interests are in outcomes research, specifically in developing clinical tools to help clinicians and patients make better informed treatment decisions. She has developed predictive tools for urgency urinary incontinence as well as helped to improve predictive tools for post-surgical complications. She is currently a Women’s Reproductive Health Research (WRHR) scholar through the NIH/NICHD where she is studying outcomes after OnbotulinumToxinA and Sacral Neuromodulation for Urgency urinary incontinence.
Clinical Locations
Urogynecology, Area E
801-213-2995
Specialties
Board Certification and Academic Information
| Academic Departments | Obstetrics/Gynecology
-
Assistant Professor (Clinical) |
| Academic Divisions | Urogynecology |
Dr. Whitney Hendrickson is a fellowship trained Urogynecologist and women’s health provider in the Urogynecology and Pelvic Reconstructive Surgery division.
Dr. Whitney Hendrickson received her M.D. from University of Massachusetts. She completed her Obstetrics and Gynecology residency from UC San Diego in San Diego, California. Following residency, Dr. Hendrickson completed a fellowship in Female Pelvic Medicine and Reconstructive Surgery at Duke University in Durham, North Carolina. Dr. Hendrickson’s clinical interest include the medical and surgical treatment of pelvic organ prolapse and urinary incontinence, especially those women whose initial treatments have not been successful. She is accepting new patients with pelvic floor disorders.
Dr. Hendrickson’s research interests are in outcomes research, specifically in developing clinical tools to help clinicians and patients make better informed treatment decisions. She has developed predictive tools for urgency urinary incontinence as well as helped to improve predictive tools for post-surgical complications. She is currently a Women’s Reproductive Health Research (WRHR) scholar through the NIH/NICHD where she is studying outcomes after OnbotulinumToxinA and Sacral Neuromodulation for Urgency urinary incontinence.
Academic Locations
School of Medicine
801-587-2267
Board Certification and Academic Information
| Academic Departments | Obstetrics/Gynecology
-
Assistant Professor (Clinical) |
| Academic Divisions | Urogynecology |
Education History
| Fellowship | Duke University Medical Center Female Pelvic Medicine and Reconstructive Surgery Fellow, 2021 |
| Internship/Residency | University of California, San Diego School of Medicine Gynecology & Reproductive Science Administrative Chief Resident, 2018 |
| Internship/Residency | University of California San Diego Medical Center Obstetrics & Gynecology Intern/Resident, 2018 |
| Residency | University of Arizona College of Medicine Integrative Medicine Elective Visiting Resident, 2017 |
| Professional Medical | University of Massachusetts Medical School Medicine; concentration in Multicultural Pathways M.D., 2014 |
| Undergraduate | Middlebury College Molecular Biology & Biochemistry B.A., 2009 |
Selected Publications - Journal Articles
Journal Article
- Hendrickson WK, Xie G, Rahn DD, Amundsen CL, Hokanson JA, Bradley M, Smith AL, Sung VW, Visco AG, Luo S, Jelovsek JE (2021). Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women. Neurourol Urodyn, 41(1), 432-447.
- Hendrickson WK, Havrilesky L, Siddiqui NY (2021). Cost-effectiveness of bacteriuria screening before urogynecologic surgery. Am J Obstet Gynecol, 226, 831.e1-831.e12.
- Harvie HS, Sung VW, Neuwahl SJ, Honeycutt AA, Meyer I, Chermansky CJ, Menefee S, Hendrickson WK, Dunivan GC, Mazloomdoost D, Bass SJ, Gantz MG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (2021). Cost-effectiveness of behavioral and pelvic floor muscle therapy combined with midurethral sling surgery vs surgery alone among women with mixed urinary incontinence: results of the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence randomized trial. Am J Obstet Gynecol, 225(6), 651.e1-651.e26.
- Hendrickson WK, Amundsen CL, Rahn DD, Meyer I, Bradley MS, Smith AL, Myers DL, Jelovsek JE, Lukacz ES (2021). Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence. Female Pelvic Med Reconstr Surg, 27(3), 140-146.
- Hendrickson WK, Amundsen CL (2021). Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J, 32, 2549-2551.
- Hendrickson WK, Amundsen CL (2020). Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J, 32, 2545-2547.
- Downey JS, Mashburn-Warren L, Ayala EA, Senadheera DB, Hendrickson WK, McCall LW, Sweet JG, Cvitkovitch DG, Spatafora GA, Goodman SD (2014). In vitro manganese-dependent cross-talk between Streptococcus mutans VicK and GcrR: implications for overlapping stress response pathways. PLoS One, 9(12), e115975.
- Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA (2014). SPINK1 protein expression and prostate cancer progression. Clin Cancer Res, 20(18), 4904-11.
- Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA (2013). Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(12), 2354-63.
- Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E (2011). Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol, 29(17), 2378-85.
- Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E (2011). Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One, 6(4), e18625.